Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Time for growth

<< Previous

Bullboard Posts

Next >>

Comment by stockfyon Aug 14, 2022 4:58am

102 Views

Post# 34894790

RE:Time for growth

CZO is debt-free. Again CZO is debt-free. Once again, CZO is debt-free. Once again, CZO has ZERO interest-bearing debt. Facts below:

https://stockhouse.com/news/press-releases/2022/05/18/ceapro-inc-reports-record-financial-results-for-first-quarter-2022-and-provides

Retiredceo2016 wrote:

Could 2nd quarter (June 2022) revenue match 1st quarter (March 2022)? If so, profit grows with revenue growth! Stock price easily over $1.00 based on the release of 2nd quarter financials in the next few weeks. Upon release of year-end audited financials can we see a $5 stock price?

I also see a nice premium in the stock price, if Ceapro were to be taken over in the next year. However, is a take over in the best interests of long term stock holders? Ceapro’s equity is $29 million vs. long-term debt of $2.6 million. Based on the recent financials; Ceapro can handle increased debt. Should Ceapro increase debt to provide the company with the capital needed to more aggressively increase revenue/earnings?

I trust the Board is discussing the options for capital! I support the Board in directing management to build a plan for aggressive growth & increased debt……..